Oracit and Trastuzumab and Hyaluronidase
Determining the interaction of Oracit and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: citric acid / sodium citrate
Brand name: Bicitra, Cytra-2, Liqui-Dual Citra, Oracit, Shohl's Solution, Virtrate-2
Synonyms: n.a.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oracit-Trastuzumab Injection (Intravenous)
- Oracit-Trastuzumab Intravenous
- Oracit-Trastuzumab-anns
- Oracit-Trastuzumab-dkst
- Oracit-Trastuzumab-dkst Intravenous
- Oracit-Trasylol
- Trastuzumab and Hyaluronidase-Orajel
- Trastuzumab and Hyaluronidase-Orajel Extra Strength
- Trastuzumab and Hyaluronidase-Oral Gel
- Trastuzumab and Hyaluronidase-Oralair
- Trastuzumab and Hyaluronidase-Oralair Adult Sample Kit
- Trastuzumab and Hyaluronidase-Oralair Childrens and Adolescents Sample Kit